Phase III, randomized, double blind, placebo controlled study of rofecoxib in colorectal cancer patients following adjuvant chemotherapy.

Trial Profile

Phase III, randomized, double blind, placebo controlled study of rofecoxib in colorectal cancer patients following adjuvant chemotherapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2013

At a glance

  • Drugs Rofecoxib (Primary)
  • Indications Colorectal cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms VICTOR
  • Most Recent Events

    • 31 May 2012 Actual end date (30 Sep 2004) added as reported by Chinese Clinical Trial Register.
    • 31 May 2012 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
    • 30 Dec 2010 Primary endpoint 'Overall-survival' has not been met
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top